top of page


Interlinked Nominated for Swecare’s Export Award
Interlinked Nominated for Swecare’s Export Award
Apr 23


Interlinked COO Returns to Uppsala University for Q-Programme Inspiration Day
Interlinked COO Returns to Uppsala University for Q-Programme Inspiration Day
Apr 2


Interlinked selected for the 2024 Innovate Nordics Acceleration Program
Interlinked selected for the 2024 Innovate Nordics Acceleration Program
Sep 11, 2024


From challenges to breakthroughs: our journey of innovation, resilience, and impact in healthcare
From navigating global challenges to driving medical breakthroughs, our journey has been remarkable in every way. Over the past few...
Sep 3, 2024


Interlinked expands global healthcare collaborations: fostering connections in china
Interlinked expands global healthcare collaborations: fostering connections in china
Aug 29, 2024


ReLink achieves registered trademark status in India, strengthening global commitment to patient safety
ReLink achieves registered trademark status in India, strengthening global commitment to patient safety
Jun 13, 2024


Exciting Milestone Achieved: FDA Registration for Innovative Healthcare Solution
Interlinked AB has reached a significant milestone with the FDA registration of our innovative solution designed to improve healthcare
Jun 2, 2024


Highlights from an Intensive May at Interlinked AB
As May wraps up, we are thrilled to share some key highlights from an incredibly productive month at Interlinked AB!
May 30, 2024


Recognising progress: our intellectual property rights portfolio expands with a new patent
Recognising progress: our intellectual property rights portfolio expands with a new patent
Mar 7, 2024


Gratitude for Recognition: Reflecting on Our Entrepreneurial Journey
We extend our heartfelt thanks for the recognition and the opportunity to share our journey. We express our gratitude to Dr. Hanadi Al...
Jan 17, 2024


Celebrating Milestones: Commencing Our Clinical Trial Journey
Embarking on a clinical trial marks a significant milestone, and we're excited to share this moment with you! We extend heartfelt...
Dec 21, 2023


Completion of ReLink Randomized Controlled Trial: A Milestone in Healthcare Innovation
We're thrilled to announce the conclusion of the ReLink randomized controlled trial, with the enrollment of the final patient marking a...
Dec 8, 2023


Expanding Our Reach: ReLink Patent Approved in Brazil!
We're delighted to share that ReLink has received patent approval in Brazil, marking a significant milestone in our journey. This...
Dec 6, 2023


Latest patent: This time it is India
Goddess Lakshami came early this year! ✨🪔 This #Diwali, our spirits are soaring even higher as we proudly announce that our...
Nov 9, 2023


We're Health Tech Challengers Finalists!
Exciting news! We're thrilled to share that we've been chosen as finalists in the Health Tech Challengers. This accolade underscores our...
Oct 10, 2023


Official logo of Tada Group & upgraded website
Explore Our Evolution: Welcome to Our Upgraded Website! 🚀 Embark on our journey of growth with the unveiling of our revamped website. 🌟...
Oct 6, 2023


ReLink/LinkUS has entered U.S. clinical trials.
Exciting News! ReLink has entered U.S. clinical trials, rebranded as LinkUS. This milestone is a testament to our commitment to...
Sep 14, 2023


Proud Moment for Tada Group AB: Patent Approval in Mexico
We've done it again! ReLink has secured its patent in Mexico. The photo captures the team celebrating this fantastic news. Let’s maintain...
Aug 31, 2023


Patent update: This time it is Malaysia
As we return from summer, our journey of global innovation continues! We're delighted to share that our ReLink technology has secured a...
Aug 17, 2023


ReLink Reaches Patients: A Landmark Achievement in Healthcare Innovation
ReLink Reaches Patients: A Landmark Achievement in Healthcare Innovation
Jul 13, 2023
bottom of page
